uniQure (QURE) Interest & Investment Income (2016 - 2026)
uniQure (QURE) posted quarterly Interest & Investment Income of $5.1 million for Q2 2026, up 43.33% year-over-year from $3.5 million in Q2 2025, and down 3.4% quarter-over-quarter from $5.2 million in Q1 2026.
Powered by 
Analysis
uniQure (QURE) Interest & Investment Income (2016 - 2026) Analysis & Trends
uniQure's Interest & Investment Income history runs 11 years deep, the most recent figure standing at $5.1 million for Q2 2026.
- In Q2 2026, Interest & Investment Income rose 43.33% year-over-year to $5.1 million; the TTM figure through Jun 2026 stood at $19.6 million (up 16.97% YoY), while the FY2025 annual figure was $17.0 million, down 20.77% from the prior year.
- Interest & Investment Income for Q2 2026 stood at $5.1 million, down from $5.2 million in the prior quarter.
- The five-year high for Interest & Investment Income was $7.5 million in Q3 2023, with the low at $35000.0 in Q2 2022.
- The 5-year median for Interest & Investment Income is $4.2 million (2024), against an average of $3.8 million.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income surged 19117.95% in 2023, then slumped 40.91% in 2024.
- uniQure's Interest & Investment Income stood at $492000.0 in 2022, then soared by 1357.11% to $7.2 million in 2023, then plunged by 40.91% to $4.2 million in 2024, then soared by 37.23% to $5.8 million in 2025, then retreated by 13.11% to $5.1 million in 2026.
- Business Quant data shows QURE's Interest & Investment Income at $5.1 million in Q2 2026, $5.2 million in Q1 2026, and $5.8 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 48.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 67.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 35.58 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 27.90 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 28.14 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 5.13 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 10.98 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn | 5.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.05 Mn |
| Mar 31, 2026 | 5.23 Mn |
| Dec 31, 2025 | 5.81 Mn |
| Sep 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 3.52 Mn |
| Mar 31, 2025 | 4.13 Mn |
| Dec 31, 2024 | 4.24 Mn |
| Sep 30, 2024 | 4.87 Mn |
| Jun 30, 2024 | 5.81 Mn |
| Mar 31, 2024 | 6.51 Mn |
| Dec 31, 2023 | 7.17 Mn |
| Sep 30, 2023 | 7.50 Mn |
| Jun 30, 2023 | 3.23 Mn |
| Mar 31, 2023 | 1.67 Mn |
| Dec 31, 2022 | 492,000.00 |
| Sep 30, 2022 | 39,000.00 |
| Jun 30, 2022 | 35,000.00 |
| Mar 31, 2022 | 42,000.00 |
| Dec 31, 2021 | 39,000.00 |
| Sep 30, 2021 | 46,000.00 |